LinkedIn Profile

Access Alexion Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
nasdaq:alxn 503126 Jun 4th, 2020 12:00AM Synageva BioPharma Corp. 11K 28.00 Open Biotechnology Jun 4th, 2020 12:27PM Jun 4th, 2020 12:27PM Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to come. Our experienced team has helped bring several life-saving therapies for diseases that were once considered too rare for development treatments. We believe that every patient deserves treatment options, no matter how rare their disease. We believe that when it comes to delivering innovative therapies, Every Second Counts. Open Open 33 Hayden Ave Lexington Massachusetts US 02421 Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Jun 4th, 2020 12:00AM Alexion Pharmaceuticals, Inc. 160K 3335 Open Biotechnology Jun 4th, 2020 12:27PM Jun 4th, 2020 12:27PM At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Jun 3rd, 2020 12:00AM Alexion Pharmaceuticals, Inc. 160K 3333 Open Biotechnology Jun 2nd, 2020 10:06PM Jun 2nd, 2020 10:06PM At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 503126 Jun 3rd, 2020 12:00AM Synageva BioPharma Corp. 11K 28.00 Open Biotechnology Jun 2nd, 2020 10:06PM Jun 2nd, 2020 10:06PM Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to come. Our experienced team has helped bring several life-saving therapies for diseases that were once considered too rare for development treatments. We believe that every patient deserves treatment options, no matter how rare their disease. We believe that when it comes to delivering innovative therapies, Every Second Counts. Open Open 33 Hayden Ave Lexington Massachusetts US 02421 Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Jun 2nd, 2020 12:00AM Alexion Pharmaceuticals, Inc. 160K 3333 Open Biotechnology Jun 2nd, 2020 11:30AM Jun 2nd, 2020 11:30AM At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 503126 Jun 2nd, 2020 12:00AM Synageva BioPharma Corp. 11K 28.00 Open Biotechnology Jun 2nd, 2020 11:30AM Jun 2nd, 2020 11:30AM Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to come. Our experienced team has helped bring several life-saving therapies for diseases that were once considered too rare for development treatments. We believe that every patient deserves treatment options, no matter how rare their disease. We believe that when it comes to delivering innovative therapies, Every Second Counts. Open Open 33 Hayden Ave Lexington Massachusetts US 02421 Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 Jun 1st, 2020 12:00AM Alexion Pharmaceuticals, Inc. 160K 3333 Open Biotechnology Jun 1st, 2020 11:07AM Jun 1st, 2020 11:07AM At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 503126 Jun 1st, 2020 12:00AM Synageva BioPharma Corp. 11K 28.00 Open Biotechnology Jun 1st, 2020 11:07AM Jun 1st, 2020 11:07AM Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to come. Our experienced team has helped bring several life-saving therapies for diseases that were once considered too rare for development treatments. We believe that every patient deserves treatment options, no matter how rare their disease. We believe that when it comes to delivering innovative therapies, Every Second Counts. Open Open 33 Hayden Ave Lexington Massachusetts US 02421 Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 503126 May 31st, 2020 12:00AM Synageva BioPharma Corp. 11K 28.00 Open Biotechnology May 30th, 2020 10:06PM May 30th, 2020 10:06PM Synageva BioPharma is a biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need. We are passionate about our commitment to improving their lives and those of their families for generations to come. Our experienced team has helped bring several life-saving therapies for diseases that were once considered too rare for development treatments. We believe that every patient deserves treatment options, no matter how rare their disease. We believe that when it comes to delivering innovative therapies, Every Second Counts. Open Open 33 Hayden Ave Lexington Massachusetts US 02421 Health Care Pharmaceuticals & Biotechnology
nasdaq:alxn 16750 May 31st, 2020 12:00AM Alexion Pharmaceuticals, Inc. 160K 3329 Open Biotechnology May 30th, 2020 10:06PM May 30th, 2020 10:06PM At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Open Biotechnology, Biopharmaceutical, Complement Inhibition, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, hematology, nephrology Open 121 Seaport Blvd Boston Massachusetts US Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.